REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Dizal (Jiangsu) Pharmaceutical Co., Ltd. (China)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Dizal (Jiangsu) Pharmaceutical Co., Ltd. Profile Updated: December 22, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Chinese Download a sample report

Dizal (Jiangsu) Pharmaceutical Co., Ltd. focuses on the exploration, R&D and commercialization of innovative drugs. The company conducts new drug research in major diseases such as malignant tumors, immune diseases and kidney diseases. The company was founded in 2017 and headquartered in Wuxi City, China.

Headquarters
Building 4, No. 199, 245 Liangjing Road, Pudong New Area Pilot Free Trade Zone, Shanghai
Wuxi; Jiangsu; Postal Code: 214135;201203

Contact Details: Purchase the Dizal (Jiangsu) Pharmaceutical Co., Ltd. report to view the information.

Website: http://www.dizalpharma.com

Basic Information
Total Employees:
Purchase the Dizal (Jiangsu) Pharmaceutical Co., Ltd. report to view the information.
Outstanding Shares:
Purchase the Dizal (Jiangsu) Pharmaceutical Co., Ltd. report to view the information.
Registered Capital:
Purchase the Dizal (Jiangsu) Pharmaceutical Co., Ltd. report to view the information.
Financial Auditors:
Purchase the Dizal (Jiangsu) Pharmaceutical Co., Ltd. report to view the information.
Incorporation Date:
October 27, 2017
Key Executives
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
General Manager
Purchase this report to view the information.
Deputy General Manager
Purchase this report to view the information.
Deputy General Manager
Ownership Details
Purchase this report to view the information.
1.76%
Subsidiaries
Dizhe (Beijing) Pharmaceutical Co., Ltd.
100%
Dizhe (Shanghai) Pharmaceutical Co., Ltd.
100%
Dizhe (Wuxi) Pharmaceutical Co., Ltd.
100%
Company Performance
Financial values in the chart are available after Dizal (Jiangsu) Pharmaceutical Co., Ltd. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency CNY. Absolute financial data is included in the purchased report.
Net sales revenue
743.97%▲
Total operating revenue
498.12%▲
Operating profit (EBIT)
21.46%▲
Net Profit (Loss) for the Period
21.63%▲
Total assets
-1.84%▼
Total equity
-59.6%▼
Operating Profit Margin (ROS)
1874.64%▲
Net Profit Margin
1875.13%▲
Return on Equity (ROE)
-71.99%▼
Debt to Equity Ratio
168.97%▲
Quick Ratio
-0.36%▼
Cash Ratio
0.1%▲

Similar companies

Sinopharm Group Company Limited
 
Shanghai Pharmaceuticals Holding Co.,Ltd
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited
 
Nanjing Pharmaceutical Company Limited
Chongqing Zhifei Biological Products Co.,Ltd.
 
Hubei Biocause Pharmaceutical Co.,Ltd.
Shenzhen Guohua Network Security Technology Co., Ltd.
 
Dali Pharmaceutical Co., Ltd
Kunming Longjin Pharmaceutical Co., Ltd.
 
Transcenta Holding Limited (Hong Kong) (创胜集团医药有限公司 (香港))
Broncus Holding Corporation (Hong Kong) (Broncus Holding Corporation (香港))
 

Related EMIS Industry Reports

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo